Literature DB >> 32271995

C─H⋯O hydrogen bonds in kinase-inhibitor interfaces.

Zygmunt S Derewenda1, Izabela Hawro1,2, Urszula Derewenda1.   

Abstract

C─H⋯O hydrogen bonds constitute a unique class of cohesive inten class="Chemical">ractions. Their properties are similar to those of canonical H-bonds, although their energy is significantly lower, typically in the 0.5-2.5 kcal/mol range. Polarised C─H groups, such as those adjacent to electronegative groups, or within aromatic moieties, are particularly strong donors. C─H⋯O bonds are ubiquitous in nucleic acids and in proteins, notably stabilizing the β-sheet secondary structure. They have also been observed in numerous protein-ligand interactions. Here, we analysed crystal structures, deposited in the Protein Data Bank, of complexes of FDA-approved protein kinase inhibitors with cognate kinases, to assess the possible role of C─Hinhibitor ⋯Oprotein hydrogen bonds. The conserved hinge motif of protein kinases with two solvent-exposed carbonyl groups and one exposed backbone amide, is well known to be involved in canonical H-bonding with inhibitors. We now find that in virtually all complexes where the inhibitor interacts with the hinge backbone, at least one of the hinge carbonyl groups accepts an H-bond from a C─H inhibitor group, which is either aromatic or adjacent to an electronegative group. These observations are important for design of hinge-binding scaffolds of novel kinase inhibitors for therapeutic use.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  hydrogen bonds; protein kinase inhibitors; protein kinases

Year:  2020        PMID: 32271995      PMCID: PMC7641297          DOI: 10.1002/iub.2282

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  23 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 3.  Carbon-oxygen hydrogen bonding in biological structure and function.

Authors:  Scott Horowitz; Raymond C Trievel
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

Review 4.  Protein kinases as drug targets in cancer.

Authors:  Mehmet Alper Arslan; Ozgur Kutuk; Huveyda Basaga
Journal:  Curr Cancer Drug Targets       Date:  2006-11       Impact factor: 3.428

Review 5.  Properties of FDA-approved small molecule protein kinase inhibitors.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2019-03-13       Impact factor: 7.658

Review 6.  A historical overview of protein kinases and their targeted small molecule inhibitors.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2015-07-21       Impact factor: 7.658

7.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 9.  Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2015-10-31       Impact factor: 7.658

10.  Overview of refinement procedures within REFMAC5: utilizing data from different sources.

Authors:  Oleg Kovalevskiy; Robert A Nicholls; Fei Long; Azzurra Carlon; Garib N Murshudov
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-03-02       Impact factor: 7.652

View more
  1 in total

1.  Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment.

Authors:  Tony Eight Lin; Chia-Ron Yang; Ching-Hsuan Chou; Jui-Yi Hsu; Min-Wu Chao; Tzu-Ying Sung; Jui-Hua Hsieh; Wei-Jan Huang; Kai-Cheng Hsu
Journal:  Biomed Pharmacother       Date:  2021-12-22       Impact factor: 6.529

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.